How Peptides Are Tested for Purity and Identity

Educational content only. Not medical advice. FeelGood does not claim that any peptide treats, cures, prevents, or mitigates any disease or condition. Consult a qualified healthcare provider before making any decisions about peptide therapy.

Peptide identity is confirmed by mass spectrometry, which measures the molecule's mass and matches it to the sequence's theoretical value. Purity is measured by reverse-phase high-performance liquid chromatography, reported as the area percent of the main peak against total peak area. The two answer different questions: identity is what the molecule is, purity is how much of the material is the target.[1]

Peptide testing establishes two separate facts about a material: what it is, and how much of it is the intended compound. Identity is confirmed by mass spectrometry, which measures the molecular mass and compares it against the value predicted by the amino-acid sequence. Purity is measured by high-performance liquid chromatography, which separates the sample and reports the target peptide as a percentage of everything detected.

Those two questions sound similar. They are not. A material can carry the correct mass and still be a minority of what sits in the vial, and a high purity figure says nothing about which molecule was purified. Identity and purity have to be answered by different instruments, and a complete picture also accounts for net peptide content, contamination, and the lot the certificate actually describes. The sections below walk through each method, what it physically measures, and where it stops.

Identity: mass spectrometry

A peptide is a defined chain of amino acids, and that sequence predicts an exact molecular mass. Mass spectrometry measures the mass of the molecules in a sample by ionizing them and sorting the resulting ions by their mass-to-charge ratio. The measured value is then compared against the theoretical mass calculated from the intended sequence. When the two agree within the instrument's tolerance, the result is consistent with the labeled compound.[1]

The technique is usually run as liquid chromatography coupled to mass spectrometry, often written LC-MS, so the sample is separated before it reaches the detector.

Mass has one structural limit worth stating plainly. Two peptides built from the same amino acids in a different order carry the same molecular formula and therefore the same mass. Mass spectrometry alone cannot tell those two apart, which is why sequence-level confirmation methods such as peptide mapping or tandem mass spectrometry exist for cases where order, not just composition, has to be proven.[1] For routine identity confirmation against a known target, the measured-versus-theoretical mass comparison is the standard check.

Purity: high-performance liquid chromatography (HPLC)

High-performance liquid chromatography is the standard method for assessing peptide purity.[2] The sample is pushed through a column packed with a stationary material, and different molecules travel through at different speeds depending on how strongly each interacts with that material. The detector records each component as it leaves the column, producing a chromatogram of separate peaks. The main peak is the intended peptide. The smaller peaks are everything else that separated out: truncated sequences, deletion products, and other synthesis byproducts.

Purity is reported as area percent. The area under the main peak is divided by the total area of all peaks, and the result is the percentage of detected material represented by the target compound.[2] Detection is almost always by ultraviolet absorbance, because the peptide bond absorbs strongly in the far ultraviolet, near 220 nm. The canonical analytical methodology places detection in the 210 to 220 nm range for exactly this reason.[3] Most analytical separations use a reversed-phase column with an acetonitrile and water gradient, the mode the published literature describes as the most widely used for peptide separations.[3]

Two facts about that number matter. First, area-percent purity is method-dependent. The detection wavelength, the column, and the gradient all shape which impurities resolve into visible peaks and which co-elute under the main one, so a purity figure is only meaningful alongside the method that produced it. Second, the grade is application-specific. Published purity guidelines tie tiers to use: separations above 95 percent serve quantitative in-vitro work, while the highest bracket, above 98 percent, is the one named for active pharmaceutical ingredients, clinical use, and sensitive bioassay.[4] A purity figure at or above 98 percent by HPLC therefore sits at the demanding end of the published scale rather than the middle of it.

Net peptide content and counterions

Purity and content are different measurements, and conflating them is the most common error in reading a result. HPLC area percent describes the proportion of the peptide-related material that is the target compound. It does not describe how much of the physical powder in the vial is peptide at all.[5]

A lyophilized peptide is not pure peptide by weight. Bound to it are water and counterions, the small acidic molecules that pair with the basic sites on the chain. Most synthetic peptides carry trifluoroacetic acid (TFA) or acetate, firmly associated with the free N-terminus and with basic side chains such as arginine, lysine, and histidine, as a salt.[5] Net peptide content is the fraction of the total mass that is actually peptide, and it is established by amino-acid analysis, which hydrolyzes the chain into its constituent amino acids and quantifies them.

The consequence is counterintuitive. A peptide rich in basic residues forms more salt, so it can show a relatively low net peptide content even when it is extremely pure by HPLC.[5] A material can be 98 percent pure and still be well under 98 percent peptide by mass, because purity counts molecules of the right kind while content weighs the substance in the vial. Both numbers describe real properties; neither substitutes for the other.

Contaminant testing: endotoxin and sterility

Purity and identity describe the peptide. They say nothing about biological contamination, and for material that could contact the bloodstream that is a separate category of testing.

Bacterial endotoxins are fragments of the outer membrane of Gram-negative bacteria. They are heat-stable, which means a sterilization step that kills the organism can leave the endotoxin behind. The pharmacopeial method for detecting them is the Bacterial Endotoxins Test, described in United States Pharmacopeia General Chapter <85>, which uses Limulus Amebocyte Lysate, a reagent derived from the blood cells of the horseshoe crab that reacts in the presence of endotoxin.[6] The test, often abbreviated LAL, has been the standard in-vitro method for evaluating parenteral products for endotoxin for decades, and the chapter sets endotoxin limits expressed in endotoxin units relative to dose.[6]

Sterility is a distinct question again, addressing whether viable microorganisms are present rather than whether bacterial fragments are. Endotoxin and sterility are different assays answering different questions, and neither is captured by a purity chromatogram. A "99 percent pure" figure on its own carries no information about either, which is why injectable-grade material is characterized by the contaminant tests in addition to identity and purity.

Batch-specific testing and the certificate of analysis

Testing describes a specific lot of material, not a product line in general. Synthesis varies between runs, so a result from one batch does not transfer to the next, and the document that records the testing, the certificate of analysis, is meaningful only when its lot number matches the lot in hand.[7] A generic certificate that travels with every shipment, rather than one generated per batch, describes material that was tested at some point rather than the material received.

Reading that certificate is its own subject, covered separately in How to Read a Certificate of Analysis for a Peptide Supplement. The accreditation that governs whether the testing lab operates under a recognized quality system, ISO/IEC 17025, is likewise its own topic, treated in ISO 17025 and Peptide Quality. The relevant point for methods is that test results attach to a lot and to a date.

That date matters for sterile material in particular. A beyond-use date, defined in United States Pharmacopeia General Chapter <797> as the date, or hour and date, after which a compounded sterile preparation must not be used, stored, or transported, sets a use deadline distinct from a manufacturer's expiration date.[8] It bounds the window in which the tested characteristics of a sterile preparation are expected to hold.

What a complete testing picture looks like

A full characterization answers several independent questions, each with its own method. No single test covers the set.

• Identity. What the molecule is. Established by mass spectrometry, comparing measured molecular mass against the theoretical mass of the sequence, with sequence-level methods where the order of residues must be proven.[1]
• Purity. What proportion of the peptide-related material is the target compound. Established by HPLC, reported as area percent of the main peak, typically with ultraviolet detection at 210 to 220 nm, and meaningful only with its method stated.[2][3]
• Net peptide content. What fraction of the physical mass is peptide rather than water and counterion. Established by amino-acid analysis, and not interchangeable with purity.[5]
• Endotoxin. Whether bacterial endotoxin is present below the defined limit, for material that could enter the bloodstream. Established by the Bacterial Endotoxins Test (LAL) under United States Pharmacopeia General Chapter <85>.[6]
• Accreditation and lot. Whether the testing was performed under a recognized quality system and whether the result describes the lot in hand. Governed by ISO/IEC 17025 for laboratory competence and by batch-specific certification tied to the lot number.[7][9]

Frequently asked questions

What tests confirm a peptide's identity?

Identity is confirmed primarily by mass spectrometry, which measures a molecule's mass and compares it against the value predicted by the intended amino-acid sequence. Agreement within the instrument's tolerance is consistent with the labeled compound. Because two peptides built from the same amino acids in a different order share the same mass, sequence-level methods such as peptide mapping or tandem mass spectrometry are used when the order of residues has to be proven, which composition alone cannot establish.[1]

How is peptide purity measured?

Purity is measured by high-performance liquid chromatography. The sample is separated on a column so that the target peptide and its byproducts emerge as distinct peaks, and purity is reported as the area of the main peak divided by the total area of all detected peaks, expressed as a percentage.[2] Detection is usually by ultraviolet absorbance near 210 to 220 nm, the range at which the peptide bond absorbs strongly.[3] The resulting figure depends on the method used to produce it.

What purity is standard for research peptides?

Published purity guidelines tie the grade to the application rather than naming one universal standard. Separations above 95 percent by HPLC are listed for quantitative in-vitro work, and the highest bracket, above 98 percent, is the one specified for active pharmaceutical ingredients, clinical use, crystallography, and sensitive bioassay.[4] A purity at or above 98 percent therefore sits at the demanding end of the documented scale. The figure is only interpretable alongside the method that generated it.

What is endotoxin testing?

Endotoxin testing detects bacterial endotoxins, heat-stable fragments of the outer membrane of Gram-negative bacteria that can survive a sterilization step that kills the organism. The pharmacopeial method is the Bacterial Endotoxins Test in United States Pharmacopeia General Chapter <85>, which uses Limulus Amebocyte Lysate, a reagent derived from horseshoe crab blood cells that reacts in the presence of endotoxin.[6] It applies to parenteral material and is reported against a defined endotoxin limit. It is separate from both purity and sterility testing.

Why does the testing method matter?

A test result is only as specific as the method behind it. An HPLC purity figure shifts with the detection wavelength, the column, and the gradient, because those choices determine which impurities resolve into visible peaks.[3] A mass measurement confirms molecular mass but not the order of residues.[1] Reporting a number without its method, or treating one test as if it answered a question it does not address, removes the context that makes the result meaningful. Each method has a defined scope and a defined limit.

What is the difference between purity and content?

Purity, by HPLC, is the proportion of the peptide-related material that is the target compound. Content, by amino-acid analysis, is the fraction of the physical powder that is peptide rather than bound water and counterion.[5] Because most synthetic peptides carry trifluoroacetic acid or acetate as a salt on their basic sites, a peptide rich in basic residues can show high HPLC purity and a comparatively low net peptide content at the same time.[5] The two numbers describe different properties, and one does not substitute for the other.

FeelGood supplies research-use-only peptides sourced in the United States and Europe. Each batch is released with a third-party certificate of analysis documenting identity by mass spectrometry, purity by high-performance liquid chromatography, and ISO 17025 accredited testing.

Footnotes

[1] Bachem. "Quality Control of Amino Acids & Peptides: A Guide." Bachem Knowledge Center. Molecular weight determined by mass spectrometry as an identity parameter; structural limit of identical mass for peptides of the same composition but different sequence. https://www.bachem.com/knowledge-center/quality-control-of-amino-acids-peptides-a-guide/

[2] Bachem. "Quality Control of Amino Acids & Peptides: A Guide." Analytical HPLC as the standard purity method; purity assessed by UV detection at 210-220 nm, where the area of the main peak relative to the total peak area reflects peptide purity. https://www.bachem.com/knowledge-center/quality-control-of-amino-acids-peptides-a-guide/

[3] Mant, C. T., Chen, Y., Yan, Z., Popa, T. V., Kovacs, J. M., Mills, J. B., Tripet, B. P., & Hodges, R. S. "HPLC Analysis and Purification of Peptides." Methods in Molecular Biology, vol. 386, 2007, pp. 3-55. Peptide bonds absorb in the far UV (~220 nm), detection generally at 210-220 nm; reversed-phase HPLC the most widely used mode; aqueous TFA to TFA/acetonitrile gradients. DOI: 10.1007/978-1-59745-430-8_1. PMID: 18604941. https://pmc.ncbi.nlm.nih.gov/articles/PMC7119934/

[4] BioCat GmbH. "Peptide Purity Guideline." HPLC purity tiers by application: above 95 percent for quantitative in-vitro bioassay, NMR, and enzymology; above 98 percent for active pharmaceutical ingredients, clinical trials, crystallography, SAR studies, and sensitive bioassay. https://www.biocat.com/peptide-synthesis/peptide-purity-guideline

[5] Bachem. "Quality Control of Amino Acids & Peptides: A Guide." Net peptide content and purity are not equivalent; most peptides contain trifluoroacetic acid or acetic acid bound as a salt to the free N-terminus and basic side chains (Arg, Lys, His); a low net peptide content is expected for peptides with a large proportion of basic amino acids even when extremely pure. https://www.bachem.com/knowledge-center/quality-control-of-amino-acids-peptides-a-guide/

[6] United States Pharmacopeia. General Chapter <85>, "Bacterial Endotoxins Test." Detection of bacterial endotoxins in parenteral products using Limulus Amebocyte Lysate (LAL) derived from amebocytes of the horseshoe crab; endotoxin limits specified per dose in endotoxin units. United States Pharmacopeial Convention. https://www.usp.org/

[7] FeelGood. "How to Read a Certificate of Analysis for a Peptide Supplement." Batch-specific certification and the role of the lot number in interpreting test results. https://feelgoodpeptide.com/blog/how-to-read-a-certificate-of-analysis-for-a-peptide-supplement

[8] United States Pharmacopeia. General Chapter <797>, "Pharmaceutical Compounding - Sterile Preparations." Beyond-use date defined as the date, or hour and the date, after which a compounded sterile preparation must not be used, stored, or transported; distinct from a manufacturer's expiration date. United States Pharmacopeial Convention. https://www.usp.org/compounding/general-chapter-797

[9] International Organization for Standardization. ISO/IEC 17025:2017, "General requirements for the competence of testing and calibration laboratories." Specifies general requirements for the competence, impartiality, and consistent operation of testing and calibration laboratories. ISO, Geneva. https://www.iso.org/standard/66912.html